Table 4.
Complications
| Overall (N = 925) | LLL (n = 655) | SDL (n = 270) | P value | |
|---|---|---|---|---|
| Implant LBBAP lead-related complications | 83 (9.0) | 40 (6.1) | 43 (15.9) | <.001 |
| Septal perforation | 56 (6.1) | 32 (4.9) | 24 (8.9) | .023 |
| Septal hematoma | 2 (0.2) | 0 | 2 (0.7) | .085 |
| Acute lead microdislodgment | 16 (2.1) | 6 (1.1) | 10 (4.7) | .003 |
| Lead damage during implant | 15 (1.6) | 3 (0.5) | 12 (4.4) | <.001 |
| Significant paced QRS changes before discharge | 46 (5.5) | 21 (3.5) | 25 (10.6) | <.001 |
| LBBAP lead dislodgment during follow-up | 10 (1.1) | 6 (0.9) | 4 (1.5) | .489 |
| Non-LBBAP lead-related complications | 13 (2.6) | 11 (3) | 2 (1.5) | .529 |
| Pocket hematoma | 8 (1.3) | 6 (1.3) | 2 (1.3) | 1 |
| Pneumothorax | 4 (0.7) | 4 (0.7) | 0 | .577 |
| Right atrial lead dislodgment | 5 (0.8) | 3 (0.7) | 2 (1.3) | .610 |
| Other | 2 (0.2) | 2 (0.3) | 0 | .549 |